Advanced Combination Therapy in Inflammatory Bowel Disease.

Fiche publication

Date publication

mai 2025

Journal

Joint bone spine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr JOUZEAU Jean-Yves , Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Morizot C, Sequier L, Jouzeau JY, Moulin D, Netter P, Caron B, Honap S, Lœuille D, Peyrin-Biroulet L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40414524

Résumé

The advent of advanced therapies in the recent years have improved outcomes for inflammatory bowel disease patients, but a significant subset of patients remains refractory to monotherapy. Advanced Combination Therapy, involving two biologic agents or a biologic combined with a small molecule drug, is emerging as a potential strategy to improve clinical remission and address extra-intestinal manifestations.